Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Alexandria Journal of Pharmaceutical Sciences. 1992; 6 (3): 285-288
em Inglês | IMEMR | ID: emr-22906

RESUMO

The effect of a short-term treatment with captopril on IV bolus digoxin kinetics has been investigated in 6 normal dogs. A dose of 0.05 mg/kg digoxin was given to each dog and blood samples were collected for digoxin assay. The dogs were then given captopril [20 mg/kg orally] for 10 days followed by a similar IV bolus dose of digoxin and blood samples were also collected for digoxin assay. The results showed that serum digoxin concentration-time curve declined biphasically in the first 24 hours after administration. The Cp max significantly decreased by 39%, while the t max was prolonged by 64%. The distribution of digoxin in the central compartment [t/1/2 alpha and Vc] was not statistically different under the effect of Captopril while the elimination phase half life [T/1/2 alpha and beta] was longer by 106% and the apparent volume of distribution [Vd] was increased by 85%. The area under the curve [AUC] was increased by 17%. These changes indicated that Captopril can reduce digoxin elimination as shown by the reduction in digoxin clearance and the increase in the AUC


Assuntos
Farmacologia , Digoxina/efeitos dos fármacos , Farmacocinética
2.
PCM ; 5(3): 9-13, 1991.
Artigo em Espanhol | LILACS | ID: lil-105319

RESUMO

La fibrilación auricular (FA) constituye un problema de salud pública por su alta frecuencia, y por los riesgos que conlleva. En este trabajo se hace la revisión actualizada de las drogas que se pueden utilizar en sus tratamientos haciendo énfasis en los pro y contras de las mismas. Además se revisan aspectos relacionados con la cardioversión y sus complicaciones. Se establecen los riesgos del accidente cerebrovascular (ACV) dependiendo de la génesis de la FA y se examinan los posibles efectos benéficos de la terapia antiagregante


Assuntos
Cardioversão Elétrica/uso terapêutico , Digoxina/efeitos dos fármacos , Fibrilação Atrial/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA